Title : Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.

Pub. Date : 1994 Jun

PMID : 7917780






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. Omeprazole cytochrome P450 family 4 subfamily F member 3 Homo sapiens
2 The in vitro metabolism of omeprazole was studied in human liver microsomes in order to define the secondary metabolic pathways and identify the cytochrome P450 (CYP) isoforms responsible for the formation of the secondary metabolites of omeprazole. Omeprazole cytochrome P450 family 4 subfamily F member 3 Homo sapiens
3 The in vitro metabolism of omeprazole was studied in human liver microsomes in order to define the secondary metabolic pathways and identify the cytochrome P450 (CYP) isoforms responsible for the formation of the secondary metabolites of omeprazole. Omeprazole cytochrome P450 family 4 subfamily F member 3 Homo sapiens
4 The in vitro metabolism of omeprazole was studied in human liver microsomes in order to define the secondary metabolic pathways and identify the cytochrome P450 (CYP) isoforms responsible for the formation of the secondary metabolites of omeprazole. Omeprazole cytochrome P450 family 4 subfamily F member 3 Homo sapiens
5 The in vitro metabolism of omeprazole was studied in human liver microsomes in order to define the secondary metabolic pathways and identify the cytochrome P450 (CYP) isoforms responsible for the formation of the secondary metabolites of omeprazole. Omeprazole cytochrome P450 family 4 subfamily F member 3 Homo sapiens